- Advanced search
- Immuno Portal
- Malaria Portal
Ligand id: 5936
View more information in the IUPHAR Pharmacology Education Project: nintedanib
Molecular properties generated using the CDK
|Nintedanib is active in vivo, its effects observed as decreased vessel density and integrity and significant growth inhibition . Nintedanib is rapidly metabolised to BIBF-1202 .
We have tagged FLT4 (VEGFR-3) as this drug's primary molecular target for data metrics purposes only. We fully acknowledge the multi-targeted nature of nintedanib and include reported kinase interactions in the table below.
|Selectivity at catalytic receptors|
|Key to terms and symbols||Click column headers to sort|